Labs and Investments
The objective of Trifork Labs is to lead the venture-financed research and development (R&D) activities of the Trifork Group.
For more than 20 years, Trifork has been active in founding and investing in tech start-ups that develop innovative software solutions. In the process of working with start-up companies, Trifork gains valuable know-how from their technological development, ensuring that it becomes familiar with emerging disruptive technologies at an early stage.
Trifork Labs investments are determined based on three well-defined investment criteria: first, the target must be a software product company that invents new technology. Second, the investment should build technology to support the Inspire, Build, or Run part of the go-to-market model. Finally, investments are evaluated based on their potential to become a strategic partner to Trifork and potential synergies that can be expected from the investment.
Trifork’s main focus in these investments is to support the R&D and our intention is not to function as an incubator or investment fund.
Trifork Labs has historically generated a positive financial result for Trifork. Until 30 June 2021, Trifork Labs has generated net financial income from valuation adjustments in the amount of EUR 84.1 million. This is measured by the Group’s aggregate realized and unrealized gains and losses and the dividend income from the investments.
Dawn Labs (49.9%)
Arkyn Studios (48.0%)
ExSeed Health (21.9%)
AxonIQ B.V. (21.5%)
Programmable Infrastructure Solutions (20.4%)
Upcycling Forum (17.8%)
Beem International Sarl (6.7%)
Verica Inc. (2.6%)
Implantica Mediswiss (0.1%)